About Moxifloxacin Hydrochloride (Anhydrous) API
Therapeutic CategoryAnti-Infective
CAS Number
186826-86-8
API Technology
Synthetic
Dose Form
Oral Solids, Injectable, Opthalmic
Dr Reddy's Development Status
Available
Available Regulatory Filing
USDMF, CEP Submitted, Brazil DMF, Canada DMF, Korea DMF, Russia DMF, Egypt DMF
Mechanism of Action
The bactericidal action of moxifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV. DNA gyrase is an essential enzyme that is involved in the replication, transcription and repair of bacterial DNA. Topoisomerase IV is an enzyme known to play a key role in the partitioning of the chromosomal DNA during bacterial cell division.
Indication
AVELOX is a fluoroquinolone antibacterial indicated for treating infections in adults 18 years of age and older caused by designated susceptible bacteria, in the conditions listed below:
- Community Acquired Pneumonia
- Skin and Skin Structure Infections: Uncomplicated and Complicated
- Complicated Intra-Abdominal Infections
- Plague
- Acute Bacterial Sinusitis
- Acute Bacterial Exacerbation of Chronic Bronchitis
To reduce the development of drug-resistant bacteria and maintain the effectiveness of AVELOX and other antibacterial drugs. AVELOX should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria VIGAMOX® solution is a topical fluoroquinolone antiinfective indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:
- Corynebacterium species*
- Micrococcus luteus*
- Staphylococcus aureus
- Staphylococcus epidermidis
- Staphylococcus haemolyticus
- Staphylococcus hominis
- Staphylococcus warneri*
- Streptococcus pneumoniae
- Streptococcus viridans group
- Acinetobacter lwoffii*
- Haemophilus influenzae
- Haemophilus parainfluenzae*
- Chlamydia trachomatis
Related APIs
Ciprofloxacin Hydrochloride
Anti-Infective
Gatifloxacin (Anhydrous)
Anti-Infective
Levofloxacin Hemihydrate
Anti-Infective
Moxifloxacin Hydrochloride (Anhydrous)
Anti-Infective
Permethrin
Anti-Infective
Posaconazole
Anti-Infective
Terbinafine Hydrochloride
Anti-Infective
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
FAQs
It is an anti infective used to treat Pneumonia, Skin Infections, Plague Bacterial Sinusitis
-
Available in Solution (IV), Tablet (Oral) - Sol - 400MG/250ML (1.6MG/ML). Tablet - 400MG base.
-
We offer an Anhydrous form
-
Meet with our product experts in one-on-one virtual sessions at https://api.drreddys.com/meet-api-experts or Write to us at [email protected].
Disclaimer
No information on this website, including any reference to any product or service constitutes an offer for sale or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, in certain cases, at Dr. Reddy's sole discretion, and subject to local legal requirement, the research quantities of such products may be offered for the purpose of regulatory submissions under Section 107A of the Indian Patent Act (Bolar exemption), wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the product or service including, patent scenario in their respective markets and will be responsible for all patent related liabilities Dr. Reddy's disclaims all warranties, express or implied, including but not limited to warranties of merchantability, fitness for a particular purpose and non-infringement.